ERBB3 and ovarian cancer: In addition, MM-141 was demonstrated to increase the therapeutic efficacy of chemotherapeutics and a mTOR inhibitor, everolimus, via regulating HER3 and IGF-1R levels in models of pancreatic and ovarian cancer[11,101,102].